ArticleCancer immunology, immunotherapy : CII2021

Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study.

Haiping Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.